Applications

1492 – Non-invasive prenatal testing (NIPT)

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type Re-application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Not supported

Application details

Reason for application

New MBS item.

Service or technology in this application

Non-invasive prenatal testing through the analysis of cell free fetal DNA is a major technological advancement in testing for fetal aneuploidy.

Type: Investigative

Medical condition this application addresses

The medical conditions relevant to the proposed service are conditions such as Down syndrome, Edward syndrome, Patau syndrome and Turner syndrome that arise where the number of chromosomes present in the patient is abnormal (aneuploidy). Prenatal screening is a routine medical service for a pregnant woman to evaluate her personal risk of fetal aneuploidy. These aneuploidies include but are not limited to; trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome) and monosomy X (Turner syndrome).

Previous applications

1461 – Non-invasive prenatal testing for common trisomies (21, 18 and 13)
1458 – Non-Invasive Prenatal Testing (NIPT)

Application documents

Consultation survey

PICO confirmation

Public summary document

Final stakeholder meeting minutes

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Meetings to consider this application

  • PASC meeting: 
    • 8 December 2016
  • ESC meeting: 
    • 8 June 2018
    • 10-11 October 2019
  • MSAC meeting: 
    • 26-27 July 2018
    • 28-29 November 2019

Stakeholder meeting

Tuesday 6 November 2018, members of MSAC, clinicians with experience and expertise in obstetrics and gynaecology, pathology, clinical genetics and genetic counselling; representatives of the applicant; representatives from consumer organisations; and representatives from the Department of Health met to discuss Non-Invasive Prenatal Testing (NIPT) for Common Trisomies (21, 18 and 13). This was not an MSAC decision forum, but a meeting that would inform the issues considered by MSAC, following its July 2018 consideration of application 1492. The final minutes of this meeting are above.